Türkiye Technology Fund (TTF)

Turkiye Technology Fund, or TTF, is a sovereign-backed fund of funds operating out of Istanbul with a mandate to channel public capital into venture firms that are pursuing strategically important technologies for Turkey, including biotechnology, AI, deep tech, and other advanced industries. Because TTF is a fund of funds rather than a direct investor, the implications for healthcare founders are indirect but significant. The vehicle does not write check directly into startups in the typical sense; instead, it allocates LP capital to GP firms whose mandates align with national technology priorities, and those GPs then invest into companies. For a founder, the relevant question is which GPs TTF backs and what those GPs look for in their portfolio companies. The geographic focus is Turkey-anchored but with international reach, and the strategic priority on biotech and AI in healthcare aligns with the broader Turkish ecosystem ambition to build a knowledge economy around domestic R&D. The right approach for a healthcare founder is therefore not to pitch TTF directly but to identify the Turkish-anchored VC firms in TTF’s GP portfolio, understand their mandates, and pitch those firms as potential leads or co-investors. Names like 212, TechOne, and Alesta will be among the obvious nodes in that network. The wrong approach is to send a direct deck to TTF expecting a venture conversation. The right entry path for indirect engagement is through Istanbul-based founder networks, through the Tubitak and KOSGEB ecosystems for grant capital, and through Turkish diaspora investors who are tracking the same opportunities. When pitching the GPs that TTF capitalizes, lead with the alignment between your company and the strategic technology priorities that drive TTF’s mandate, because that alignment expands the pool of capital available to those GPs and therefore makes your company more attractive to them. Caveats: information on TTF’s GP portfolio and check pacing is opaque relative to private-sector LPs, and founders should not assume that a connection at TTF translates into priority access to a downstream GP. The check size data is not publicly disclosed at the company level because TTF does not write company-level checks. Treat TTF as a structural feature of the Turkish funding landscape rather than as a direct counterparty.